Peer Review History

Original SubmissionApril 7, 2021
Decision Letter - Oded Cohen, Editor

PONE-D-21-11232

Comparative effectiveness of ultrasound-guided and anatomic-landmark percutaneous dilatational tracheostomy: a systematic review and meta-analysis

PLOS ONE

Dear Dr. Yan-Ren,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Oded Cohen

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Thank you for stating the following financial disclosure:

“NO”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

The authors have done good job in their manuscript, as reflected in the reviewers' comments. I agree that for this paper to be published, a thorough English editing is needed, by a professional English Editor.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear editor and authors- thanks you for considering me to review this paper.

This work thoroughly covers the knowledge regarding UPT vs. LT

a few minor issues to be considered:

1. safety of BPT - in the introduction there is some concern regarding high ICP and high AW pressure with BPT. the BPT safety has been reported in other trials. regarding the high ICP- bronchoscopy is done in TBI patients for other indications as well and it is not clear from the reference if that is a consequence of insufficient sedation . as for high AW pressures - again- the high AW pressure in BPT is secondary to high resistance and so the relation to PNX is loose.

2. total tracheostomy placement time is considered in only 2 papers (the third was measured differently) and so the data are limited to conclude that UPT is not associated with time reduction, or the other way around .

Reviewer #2: This study is a systematic review and meta analysis comparing ultrasound guided percutaenous dilatation tracheostomy compared to anatomical landmark percutaenous dilatation tracheostomy.

The study was well planned and well executed.

There are several minor revisions I would suggest:

-While the English in the study is intelligible, the manuscript, and especially the discussion section would benefit from linguistic editting.

- Abstract :

Numbered references are not used in abstracts. Please revise.

- Results:

The font in figure 5 is too small, and it is lacking headlines.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Stavi, Dekel

Reviewer #2: Yes: Yael Shapira-Galitz

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor:

Enclosed is our revised manuscript (Re: PONE-D-21-11232 Comparative effectiveness of ultrasound-guided and anatomic landmark percutaneous dilatational tracheostomy: A systematic review and meta-analysis). We appreciate your constructive comments, and we have made revisions accordingly.

Please find our responses to your comments below.

1. The authors have done good job in their manuscript, as reflected in the reviewers' comments. I agree that for this paper to be published, a thorough English editing is needed, by a professional English Editor

Answer: We appreciate your comments. This manuscript has been revised by a professional English editing service (https://www.aje.com).

Dear Reviewer #1 :

Enclosed is our revised manuscript (Re: PONE-D-21-11232 Comparative effectiveness of ultrasound-guided and anatomic landmark percutaneous dilatational tracheostomy: a systematic review and meta-analysis). We appreciate your constructive comments, and we have made revisions accordingly.

Please find our responses to your comments below.

1. Safety of BPT - in the introduction there is some concern regarding high ICP and high AW pressure with BPT. the BPT safety has been reported in other trials. regarding the high ICP- bronchoscopy is done in TBI patients for other indications as well and it is not clear from the reference if that is a consequence of insufficient sedation. as for high AW pressures - again- the high AW pressure in BPT is secondary to high resistance and so the relation to PNX is loose.

Answer: We appreciate your comments. We added reference No. 6 to explain that the benefit of decreasing complications was controversial under BGT in the “Introduction” section. The previous sentence that BGT was not suitable for traumatic brain injury patients has been removed. We also edited the explanation for BGT-induced high airway pressure and removed the original pneumothorax complications in the revised manuscript.

On page 4 line 9: BGT provides benefits in the real-time confirmation of needle placement, midline positioning of the needle, and avoidance of posterior tracheal wall injury [4,5]. However, the benefit of reducing the complication rate is not significantly observed [6,7]. A previous study also noted that increased airway resistance during BGT would secondary increase high airway pressure [8]. Therefore, considering patient safety and cost effectiveness, BGT is challenging among PDT procedures [7].

2. Total tracheostomy placement time is considered in only 2 papers (the third was measured differently) and so the data are limited to conclude that UPT is not associated with time reduction, or the other way around.

Answer: We agree with your comments. Considering that the total tracheostomy placement time was considered in only two papers, we modified the conclusion that the comparison of total tracheostomy placement time between UGT and LT should be further investigated.

On Page 3 line 3: The total tracheostomy placement time comparison between UGI and LT was inconclusive.

On Page 23 line 1: Since the total tracheostomy placement time was considered in only two articles, it was difficult to conclude whether UGT could reduce total tracheostomy placement time compared with LT.

On Page 24 line 6: The total tracheostomy placement time between UGT and LT should be further investigated.

Dear Reviewer #2:

Enclosed is our revised manuscript (Re: PONE-D-21-11232 Comparative effectiveness of ultrasound-guided and anatomic landmark percutaneous dilatational tracheostomy: a systematic review and meta-analysis). We appreciate your constructive comments, and we have made revisions accordingly.

Please find our responses to your comments below.

1.-While the English in the study is intelligible, the manuscript, and especially the discussion section would benefit from linguistic editing.

Answer: We appreciate your comments. We have revised the manuscript, especially the “Discussion” section, for coherence. Additionally, this manuscript has been revised by a professional English editing service (https://www.aje.com).

2.- Abstract: Numbered references are not used in abstracts. Please revise.

- Results: The font in figure 5 is too small, and it is lacking headlines.

Answer: We appreciated your suggestions. The numbered references were deleted from the “Abstract,” and Figure 5 was modified for clarity in the revised manuscript. Please see the Abstract and Figure 5.

Attachments
Attachment
Submitted filename: Response to Reviewers0808.docx
Decision Letter - Oded Cohen, Editor

Comparative effectiveness of ultrasound-guided and anatomic-landmark percutaneous dilatational tracheostomy: a systematic review and meta-analysis

PONE-D-21-11232R1

Dear Dr. Yan-Ren,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Oded Cohen

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

I wish to commend the authors for a very well written paper

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Yael Shapira-Galitz

Formally Accepted
Acceptance Letter - Oded Cohen, Editor

PONE-D-21-11232R1

Comparative effectiveness of ultrasound-guided and anatomic landmark percutaneous dilatational tracheostomy: A systematic review and meta-analysis

Dear Dr. Lin:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Oded Cohen

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .